BECN1 and BRCA1 Deficiency Sensitizes Ovarian Cancer to Platinum Therapy and Confers Better Prognosis
Amreen Salwa 1 , Alessandra Ferraresi 1 , Menaka Chinthakindi 1 , Letizia Vallino 1 , Chiara Vidoni 1 , Danny N Dhanasekaran 2 , Ciro Isidoro 1 Affiliations 1 Laboratory of Molecular Pathology, Department of Health Sciences, Università del Piemonte Orientale “A. Avogadro”, Via Solaroli 17, 28100 Novara, Italy. 2 Stephenson Cancer Center, The University of Oklahoma Health Sciences…